WallStreetZen

NYSE: GSK
Glaxosmithkline Plc Earnings & Revenue

GSK past earnings growth

How has GSK's earnings growth performed historically?
Company
9.1%
Industry
16.9%
Market
81.79%
GSK's earnings have grown faster (51.51% per year) than the US Drug Manufacturers - General industry average (7.63%)
Performance
GSK's earnings have grown faster (51.51% per year) than the US market average (21.85%)
Performance
GSK's earnings growth is slowing down - its growth over the last year (9.1%) is below its 5-year compound annual rate (51.51%)
Performance

GSK past revenue growth

How has GSK's revenue growth performed historically?
Company
3.53%
Industry
12.06%
Market
33.05%
GSK's revenue has grown slower (4.77% per year) than the US Drug Manufacturers - General industry average (4.8%)
Performance
GSK's revenue has grown slower (4.77% per year) than the US market average (17.43%)
Performance
GSK's revenue growth is slowing down - its growth over the last year (3.53%) is below its 5-year compound annual rate (4.77%)
Performance

GSK earnings and revenue history

Current Revenue
$44.4B
Current Earnings
$7.2B
Current Profit Margin
16.2%

GSK Return on equity

Current Company
36.7%
Current Industry
31.9%
Current Market
30.7%
GSK's Return on Equity (36.7%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

GSK Return on assets

Current Company
6.5%
Current Industry
6.8%
Current Market
6.4%
GSK is generating lower Return on Assets (6.5%) than the US Drug Manufacturers - General industry average (7.03%)
Performance

GSK Return on capital employed

Current Company
11.77%
Current Industry
11.3%
GSK has gotten more efficient at generating Return on Capital (11.77%) compared to 3 years ago (10.65%)
Performance

Glaxosmithkline Earnings & Revenue FAQ

What were GSK's earnings last quarter?

Glaxosmithkline (NYSE: GSK) reported Q1 2021 earnings per share (EPS) of $0.59, up 23.31% year over year. Total Glaxosmithkline earnings for the quarter were $1.47 billion. In the same quarter last year, Glaxosmithkline's earnings per share (EPS) was $0.77.

What was GSK's earnings growth in the past year?

As of Q3 2021, Glaxosmithkline's earnings has grown 9.1% year over year. This is 7.8 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 16.9%. Glaxosmithkline's earnings in the past year totalled $7.30 billion.

What was GSK's revenue last quarter?

Glaxosmithkline (NYSE: GSK) reported Q1 2021 revenue of $10.16 billion up 8.33% year over year. In the same quarter last year, Glaxosmithkline's revenue was $11.09 billion.

What was GSK's revenue growth in the past year?

As of Q3 2021, Glaxosmithkline's revenue has grown 3.53% year over year. This is 8.53 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.06%. Glaxosmithkline's revenue in the past year totalled $45.04 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.